#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epilepsy Cholestatic pruritus Rosai-Dorfman syndrome Restless legs syndrome Malignant fibrous histiocytoma Central nervous system neoplasm MELAS syndrome Oropharyngeal cancer recurrent Thermal burn Stress cardiomyopathy Penile cancer Cystic fibrosis lung Autoimmune haemolytic anaemia Leukocyte adhesion deficiency Cholangiocarcinoma More trials…

    Learn about Rare Diseases

    Angiosarcoma metastatic – Life with Disease Krabbe’s disease – Diagnostics Kearns-Sayre syndrome – Life with Disease Alport’s syndrome – Treatment Pulmonary sarcoidosis – Trials in Disease Nephroblastoma – Basic Information Behcet’s syndrome – Diagnostics Nephroblastoma – Diagnostics Prolymphocytic leukaemia – Treatment Leukoencephalopathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sonidegib Rosuvastatin Zinc Sodium Citrate Pyrazinamide Enfuvirtide Sabirnetug Apixaban SGT-003 Al8326 Cholesterol Ecubectedin Prs-344 Ifosfamide Sodium Hypochlorite SRSD107 Folic Acid, Anhydrous Wt1 Lamp Mrna Dc S095035 HRS 9531 Cpk850 More therapies…

    Learn about Your Condition

    Pancreatitis relapsing Fibrous dysplasia of bone Renal transplant Small for dates baby Thromboangiitis obliterans Glioblastoma Meniscus operation Medulloblastoma recurrent Immunodeficiency congenital Non-Hodgkin's lymphoma Ovarian cancer recurrent Follicular lymphoma Compulsive sexual behaviour Osteosarcoma Incontinence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uveitis

  • Study on the Effectiveness and Safety of Tocilizumab and Adalimumab for Patients with Severe Uveitis in Behçet’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Behcet’s syndrome
    • Uveitis
    Investigated Drugs:
    • Adalimumab
    • Tocilizumab
    France

  • Study Comparing Adalimumab and Mycophenolate Mofetil for Patients with Steroid-Dependent Non-Infectious Uveitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Uveitis
    Investigated Drugs:
    • Isoniazid
    • Indocyanine Green
    • Rifampicin
    France

  • A study to evaluate the safety of REGN7041 in adults with active noninfectious uveitis affecting the back of the eye.

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Uveitis
    France

  • Study on the Effects of Brepocitinib and Prednisone for Adults with Active Non-Infectious Uveitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chorioretinitis
    • Uveitis
    Investigated Drugs:
    • Brepocitinib Tosilate
    • Prednisone
    Austria Belgium Czechia Germany Greece Hungary +3

  • Study on Izokibep for Patients with Non-infectious Uveitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Chorioretinitis
    • Uveitis
    Investigated Drugs:
    • Izokibep
    Austria Czechia France Germany Italy Spain

  • Study of Baricitinib and Adalimumab for Children Aged 2 to 17 with Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Uveitis
    Investigated Drugs:
    • Adalimumab
    • Baricitinib
    Germany Italy Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!